TANGRAM THERAPEUTICS

Serial Number 99163593
641

Registration Progress

Application Filed
Apr 30, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Dec 20, 2025 42 days

Trademark Image

TANGRAM THERAPEUTICS

Basic Information

Serial Number
99163593
Filing Date
April 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Sep 20, 2025
Application
Pending
Classes
005 042

Rights Holder

E-THERAPEUTICS PLC

76
Address
4 Kingdom Street
LONDON W2 6BD
GB

Ownership History

E-THERAPEUTICS PLC

Original Applicant
76
LONDON GB

Legal Representation

Attorney
Anna King

USPTO Deadlines

Next Deadline
42 days remaining
Non-Final Action Mailed
Due Date
December 20, 2025
Extension Available
Until March 20, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

7 events
Date Code Type Description Documents
Sep 20, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 20, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 30, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 30, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals; short interfering RNA (siRNA) medicines and pharmaceuticals; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation.
Class 042
Scientific research and development; pharmaceutical research and development services; drug discovery services; human genetic research; scientific and technical data analysis in the field of pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer software platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) featuring computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; design and development of computer-simulated models; Software as a Service (SaaS); provision of information, advice and consultancy services relating to all of the aforesaid.

Classification

International Classes
005 042